Patent details
EP3102609 Title: METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
Basic Information
- Publication number:
- EP3102609
- PCT Application Number:
- US2015014520
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP157463993
- PCT Publication Number:
- WO2015120096
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
- French Title of Invention:
- MÉTHODES DE PRODUCTION DE LYMPHOCYTES T AUTOLOGUES UTILISÉS POUR TRAITER LES TUMEURS MALIGNES À LYMPHOCYTES B ET D'AUTRES CANCERS, ET COMPOSITIONS ASSOCIÉES
- German Title of Invention:
- VERFAHREN ZUR HERSTELLUNG AUTOLOGER T-ZELLEN ZUR BEHANDLUNG VON B-ZELL-MALIGNOMEN UND ANDEREN KREBSARTEN UND ZUSAMMENSETZUNGEN DAVON
- SPC Number:
-
LUC50001
Dates
- Filing date:
- 04/02/2015
- Grant date:
- 28/08/2024
- EP Publication Date:
- 14/12/2016
- PCT Publication Date:
- 13/08/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/08/2024
- EP B1 Publication Date:
- 28/08/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 04/02/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/09/2024
- Name:
- Kite Pharma, Inc.
- Address:
- 2400 Broadway, Santa Monica, CA 90404, United States (US)
- Name:
- The United States of America, as Represented by The Secretary, Department of Health and Human Services
- Address:
- Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive Suite 700, MSC 7788, Bethesda, Maryland 20892-7788, United States (US)
History of Owners
- From:
- 21/08/2024
- To:
- 27/09/2024
- Name:
- Kite Pharma, Inc.
- Address:
- 2225 Colorado Ave., Santa Monica, CA 90404, United States (US)
- Name:
- The United States of America, as Represented by The Secretary, Department of Health and Human Services
- Address:
- Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive Suite 700, MSC 7788, Bethesda, Maryland 20892-7788, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 06/09/2024
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- BETTER, Marc
- Address:
- United States (US)
2
- Name:
- ROSENBERG, Steven A.
- Address:
- United States (US)
3
- Name:
- FELDMAN, Steven A.
- Address:
- United States (US)
Priority
- Priority Number:
- 201461935833 P
- Priority Date:
- 04/02/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C12N 5/0783; A61K 39/00; A61K 38/17; C07K 14/725; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202435
- Publication date:
- 28/08/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202444
- Publication date:
- 30/10/2024
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
- 02/03/2026
- Annual Fee Number:
- 12
- Annual Fee Amount:
- 165 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 27/01/2025
- Last Annual Fee Paid Number:
- 11
- Last Annual Fee Paid Amount:
- 148 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 04/09/2024 | Power Of Attorney | 1 |
| 06/09/2024 | Outgoing Correspondence | 1 |